Pulmonary vascular disease & thromboembolism

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension

Circ Heart FailPublished Prospective cohort study

Authors' conclusion

RVFnRec defined by RV end-diastolic volume therapeutic decrease of -15 mL predicts exercise capacity, freedom from clinical worsening, and nears normalization. A therapeutic improvement of compliance is superior to other measures of afterload in predicting RVFnRec. RVFnRec is also associated with increased RV output reserve at exercise.

Study context

Population
Incident patients with pulmonary arterial hypertension, assessed at diagnosis and after treatment (≈11 months)63 PAH patients
Exposure
RVFnRec vs no RVFnRec after PAH treatment
  • RVFnRecn = 22
  • Controlsn = 62
Outcome
Definition of RVFnRec: therapeutic CMR changes relative to VO2peak >15 mL/(kg·min), by ROC analysis
Follow-up
≈11 months
Methodological detailsmatched healthy controls (PVDOMICS)
  • Matched healthy controls (PVDOMICS)

Main finding

As reported in the abstract

RV end-diastolic volume drop defining RVFnRec

RVFnRec

35%

22

Drop in right ventricular (RV) end-diastolic volume of −15 mL best defined RVFnRec, AUC
0.87
P value
P = 0.0001

Observational data: associations, not effects.

Further findings

OutcomeRVFnRecNo RVFnRecP value
Clinical worseningRVFnRec vs No RVFnRec · 1 out of 21 vs 17 out of 425%40%P = 0.006

Increase in compliance predicting RVFnRec

Therapy-associated increase of 0.8 mL/mm Hg in compliance, AUC
0.76
95% CI
0.64-0.88
P value
P = 0.001

Stroke volume and cardiac output at exercise

RVFnRec patients had greater increases in stroke volume and cardiac output at exercise

Original publication

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension. Circ Heart Fail. Published 4 September 2023. doi:10.1161/circheartfailure.123.010555

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.